Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "SEC"

3686 News Found

Asia emerges new hotspot for healthcare ransomware, says report
Digitisation | April 08, 2026

Asia emerges new hotspot for healthcare ransomware, says report

Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs


IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals
Digitisation | April 08, 2026

IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals

AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17


Transgene and NEC join forces to advance personalized cancer vaccine
R&D | April 08, 2026

Transgene and NEC join forces to advance personalized cancer vaccine

TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor


Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion
News | April 08, 2026

Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion

The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio


Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals
News | April 08, 2026

Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals

The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701


Zydus gets USFDA final approval for generic Dapagliflozin with 180-day shared exclusivity
Drug Approval | April 08, 2026

Zydus gets USFDA final approval for generic Dapagliflozin with 180-day shared exclusivity

Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility


Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Biopharma | April 07, 2026

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline


AstraZeneca India, Telangana Govt partner for AI-led lung cancer screening in public hospitals
Digitisation | April 07, 2026

AstraZeneca India, Telangana Govt partner for AI-led lung cancer screening in public hospitals

MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations


Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore
News | April 07, 2026

Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore

The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management